Altimmune Shares Volatile After Presentation of Positive Flu Vaccine Data at IDWeek

Altimmune Inc ALT shares have been on a roller coaster ride since mid-September, swinging in a wild range of $26.23 to $4.27. 

The shares were jumping 28.87 percent to $9.33 in premarket trading Monday before falling more than 30 percent to $5.06 after the open. 

What Happened

Altimmune presented an oral abstract on its intranasal influenza vaccine NasoVax at the IDWeek conference held in San Francisco over the weekend.

The presentation made Oct. 6 showed that NasoVAX was well-tolerated and elicited comparable antibody responses and nearly sixfold higher cellular immune response than Sanofi SA SNY's Fluzone injectable influenza vaccine.

The Phase 2 study evaluated 60 healthy adults randomized to three doses of monovalent NasoVAX formulations or saline placebo, all given as a 0.25 ml nasal spray in each nostril. A parallel cohort of 20 subjects were dosed with Fluzone.

The study participants were assessed for safety, including solicited local and systemic side effects.

The immune responses studied included hemagglutination inhibition and neutralizing antibody at days one, 15, 29, 90 and 180, and ɣ-interferon ELISpot at days one and eight. 

What's Next

Citing the additional positive Phase 2a data released in early September, Altimmune said it expects to initiate additional Phase 2 studies in 2019.

Related Links:

The Week Ahead In Biotech: Conferences, Clinical Trial Results And IPOs

Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates

Posted In: IDWeekinfluenzavaccineBiotechNewsMoversTrading Ideas

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.